ARTICLE | Company News
Tobira, Allergan deal
November 3, 2016 11:21 PM UTC
Allergan completed its acquisition of Tobira for $28.35 per share in cash, plus a contingent value right (CVR) (see BioCentury, Sept. 26)....
Allergan completed its acquisition of Tobira for $28.35 per share in cash, plus a contingent value right (CVR) (see BioCentury, Sept. 26)....